168 related articles for article (PubMed ID: 21768159)
1. Increased prefrontal cortical D₁ receptors in drug naive patients with schizophrenia: a PET study with [¹¹C]NNC112.
Abi-Dargham A; Xu X; Thompson JL; Gil R; Kegeles LS; Urban N; Narendran R; Hwang DR; Laruelle M; Slifstein M
J Psychopharmacol; 2012 Jun; 26(6):794-805. PubMed ID: 21768159
[TBL] [Abstract][Full Text] [Related]
2. Decreased binding of [11C]NNC112 and [11C]SCH23390 in patients with chronic schizophrenia.
Kosaka J; Takahashi H; Ito H; Takano A; Fujimura Y; Matsumoto R; Nozaki S; Yasuno F; Okubo Y; Kishimoto T; Suhara T
Life Sci; 2010 May; 86(21-22):814-8. PubMed ID: 20361984
[TBL] [Abstract][Full Text] [Related]
3. Nicotine normalizes increased prefrontal cortical dopamine D1 receptor binding and decreased working memory performance produced by repeated pretreatment with MK-801: a PET study in conscious monkeys.
Tsukada H; Miyasato K; Nishiyama S; Fukumoto D; Kakiuchi T; Domino EF
Neuropsychopharmacology; 2005 Dec; 30(12):2144-53. PubMed ID: 15856080
[TBL] [Abstract][Full Text] [Related]
4. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.
Slifstein M; van de Giessen E; Van Snellenberg J; Thompson JL; Narendran R; Gil R; Hackett E; Girgis R; Ojeil N; Moore H; D'Souza D; Malison RT; Huang Y; Lim K; Nabulsi N; Carson RE; Lieberman JA; Abi-Dargham A
JAMA Psychiatry; 2015 Apr; 72(4):316-24. PubMed ID: 25651194
[TBL] [Abstract][Full Text] [Related]
5. Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: a PET study with [¹¹C]NNC112.
Thompson JL; Rosell DR; Slifstein M; Girgis RR; Xu X; Ehrlich Y; Kegeles LS; Hazlett EA; Abi-Dargham A; Siever LJ
Psychopharmacology (Berl); 2014 Oct; 231(21):4231-40. PubMed ID: 24781514
[TBL] [Abstract][Full Text] [Related]
6. In vivo binding of the dopamine-1 receptor PET tracers [¹¹C]NNC112 and [¹¹C]SCH23390: a comparison study in individuals with schizophrenia.
Poels EM; Girgis RR; Thompson JL; Slifstein M; Abi-Dargham A
Psychopharmacology (Berl); 2013 Jul; 228(1):167-74. PubMed ID: 23460265
[TBL] [Abstract][Full Text] [Related]
7. Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study.
Bodén R; Persson J; Wall A; Lubberink M; Ekselius L; Larsson EM; Antoni G
Transl Psychiatry; 2017 Mar; 7(3):e1050. PubMed ID: 28267149
[TBL] [Abstract][Full Text] [Related]
8. Prefrontal dopamine D1 receptors and working memory in schizophrenia.
Abi-Dargham A; Mawlawi O; Lombardo I; Gil R; Martinez D; Huang Y; Hwang DR; Keilp J; Kochan L; Van Heertum R; Gorman JM; Laruelle M
J Neurosci; 2002 May; 22(9):3708-19. PubMed ID: 11978847
[TBL] [Abstract][Full Text] [Related]
9. D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients.
Stenkrona P; Matheson GJ; Halldin C; Cervenka S; Farde L
Int J Neuropsychopharmacol; 2019 Jul; 22(7):415-425. PubMed ID: 30958880
[TBL] [Abstract][Full Text] [Related]
10. Brain dopamine d1 receptors in twins discordant for schizophrenia.
Hirvonen J; van Erp TG; Huttunen J; Aalto S; Någren K; Huttunen M; Lönnqvist J; Kaprio J; Cannon TD; Hietala J
Am J Psychiatry; 2006 Oct; 163(10):1747-53. PubMed ID: 17012685
[TBL] [Abstract][Full Text] [Related]
11. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia.
Karlsson P; Farde L; Halldin C; Sedvall G
Am J Psychiatry; 2002 May; 159(5):761-7. PubMed ID: 11986129
[TBL] [Abstract][Full Text] [Related]
12. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia.
Abi-Dargham A; Moore H
Neuroscientist; 2003 Oct; 9(5):404-16. PubMed ID: 14580124
[TBL] [Abstract][Full Text] [Related]
13. Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys.
Tsukada H; Nishiyama S; Fukumoto D; Sato K; Kakiuchi T; Domino EF
Neuropsychopharmacology; 2005 Oct; 30(10):1861-9. PubMed ID: 15841110
[TBL] [Abstract][Full Text] [Related]
14. Imaging cortical dopamine D1 receptors using [11C]NNC112 and ketanserin blockade of the 5-HT 2A receptors.
Catafau AM; Searle GE; Bullich S; Gunn RN; Rabiner EA; Herance R; Radua J; Farre M; Laruelle M
J Cereb Blood Flow Metab; 2010 May; 30(5):985-93. PubMed ID: 20029452
[TBL] [Abstract][Full Text] [Related]
15. Altered prefrontal dopaminergic function in chronic recreational ketamine users.
Narendran R; Frankle WG; Keefe R; Gil R; Martinez D; Slifstein M; Kegeles LS; Talbot PS; Huang Y; Hwang DR; Khenissi L; Cooper TB; Laruelle M; Abi-Dargham A
Am J Psychiatry; 2005 Dec; 162(12):2352-9. PubMed ID: 16330601
[TBL] [Abstract][Full Text] [Related]
16. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.
Okubo Y; Suhara T; Suzuki K; Kobayashi K; Inoue O; Terasaki O; Someya Y; Sassa T; Sudo Y; Matsushima E; Iyo M; Tateno Y; Toru M
Nature; 1997 Feb; 385(6617):634-6. PubMed ID: 9024661
[TBL] [Abstract][Full Text] [Related]
17. Relationship of frontal D(2/3) binding potentials to cognition: a study of antipsychotic-naive schizophrenia patients.
Fagerlund B; Pinborg LH; Mortensen EL; Friberg L; Baaré WF; Gade A; Svarer C; Glenthøj BY
Int J Neuropsychopharmacol; 2013 Feb; 16(1):23-36. PubMed ID: 22338593
[TBL] [Abstract][Full Text] [Related]
18. Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment.
Yang CR; Chen L
Neuroscientist; 2005 Oct; 11(5):452-70. PubMed ID: 16151046
[TBL] [Abstract][Full Text] [Related]
19. Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia.
Guo N; Hwang DR; Lo ES; Huang YY; Laruelle M; Abi-Dargham A
Neuropsychopharmacology; 2003 Sep; 28(9):1703-11. PubMed ID: 12813475
[TBL] [Abstract][Full Text] [Related]
20. COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET.
Slifstein M; Kolachana B; Simpson EH; Tabares P; Cheng B; Duvall M; Frankle WG; Weinberger DR; Laruelle M; Abi-Dargham A
Mol Psychiatry; 2008 Aug; 13(8):821-7. PubMed ID: 18317466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
